Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy

2019182 citationsJournal Article

Authors

Good health and well-being

Published in: European Journal of Pharmacology

Volume 864, pp. 172715-172715

Field-Weighted Citation Impact: 6.25